DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves premarket: General Electric, Salesforce, Alibaba and more
▼ + stars: | 2023-01-04 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Check out the companies making headlines in premarket trading. Shares of GE were up about 2% in premarket trading. Microsoft — Microsoft shares dropped about 2% after UBS downgraded the tech giant to neutral from buy. Merck — Merck's stock rose about 1.7% after being upgraded to buy from neutral by Bank of America. Honeywell — Shares of Honeywell slipped 1.8% in the premarket after being double downgraded by UBS to sell from buy.

☆ Jim Cramer's top 10 things to watch in the market Wednesday: Tech layoffs, bank double downgrade, opportunities in industrials
▼ + stars: | 2023-01-04 | by ( Jim Cramer | ) www.cnbc.com time to read: +4 min

Analysts lower their rating on the tech giant to neutral from buy and their price target to $250 per share from $300. Analysts also cut price target to $100 per share from $118. Analysts trim price target to $193 per share from $220. BofA raises Merck (MRK) rating to buy from neutral and price target to $130 per share from $110. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ GE Healthcare is well-positioned for steady growth
▼ + stars: | 2023-01-04 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGE Healthcare is well-positioned for steady growth with above average profitabilityNicholas Heymann, Head of Global Industrial Infrastructure at William Blair, joins Worldwide Exchange to discuss GE's healthcare spin-off.

☆ J&J's consumer health unit Kenvue files for IPO, moving closer to spin-off
▼ + stars: | 2023-01-04 | by ( ) www.reuters.com time to read: +2 min

Jan 4 (Reuters) - Johnson & Johnson's (JNJ.N) consumer health unit Kenvue on Wednesday filed to be listed as an independent company, bringing the healthcare conglomerate a step closer to completing the biggest shakeup in its 135-year history. The filing, for Kenvue to list on the New York Stock Exchange under the ticker symbol "KVUE", comes more than a year after Johnson & Johnson announced its plan to break up into two companies. J&J's pharmaceutical and medical equipment units, which make cancer treatments and surgical tools, had recorded nearly $80 billion in sales in 2021, far ahead of its consumer products revenues. General Electric's (GE.N) spun-off healthcare unit, GE HealthCare Technologies , debuted as an independent company on Nasdaq on Wednesday. Kenvue said J&J will continue to own at least 80.1% of the voting power of the company's shares upon completion of the offering.

☆ GE HealthCare begins trading after spinoff from General Electric
▼ + stars: | 2023-01-04 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGE HealthCare begins trading after spinoff from General ElectricGE Healthcare CEO Peter Arduini joins CNBC’s 'Squawk on the Street' to discuss the public debut of the company. Today, the company has officially started trading as an independent company on the Nasdaq exchange under the ticker symbol ‘GEHC.’

☆ General Electric Set to Spin Off Health Unit—Putting Focus Back on Power Division
▼ + stars: | 2023-01-02 | by ( Thomas Gryta | ) www.wsj.com time to read: 1 min

General Electric’s wind and gas turbine businesses are expected to be combined with other GE energy businesses into GE Vernova, to split off in early 2024. General Electric Co. will start 2023 by splitting off its healthcare unit, completing a key step in the slow-motion breakup of the industrial giant. For the rest of the year it will face questions about the next big step: shedding its power businesses. GE HealthCare Technologies Inc. will start trading this week, leaving the once-sprawling conglomerate with three divisions: jet engines, natural gas-powered turbines and wind turbines. The gas and wind turbines are expected to be combined with other GE energy businesses into a new company called GE Vernova that will split off in early 2024.

☆ Stocks making the biggest moves premarket: Tesla, Cal-Maine, Southwest and others
▼ + stars: | 2022-12-29 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Cal-Maine Foods (CALM) – Cal-Maine slid 4.9% in premarket trading after its quarterly earnings came in below Wall Street forecasts. General Electric (GE) – GE spin-off GE HealthCare Technologies will join the S&P 500 when it begins trading as a separate public company on Jan. 4. Vornado will replace logistics company RXO (RXO), which will move to the S&P SmallCap 600. GE HealthCare — trading on a when-issued basis — rose 1% in the premarket, while Vornado was marginally lower and RXO jumped 3.3%. Apple (AAPL) – Apple is up 1% in premarket trading after closing Wednesday at a 1-1/2 year low.

☆ Stocks making the biggest moves midday: Netflix, Cal-Maine Foods, Southwest and more
▼ + stars: | 2022-12-29 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Cal-Maine Foods — Cal-Maine shares shed 15% after reporting earnings that fell short of Wall Street's expectations even as the egg producer reported record sales. Southwest Airlines — The airline stock rose more than 3%, paring back losses from the previous session when it dropped more than 5%. Severe disruptions at Southwest Airlines have drawn outsized criticism from frustrated travelers, who have dealt with thousands of canceled flights from airlines this week because of winter weather. Southwest Airlines canceled another 60% of its flights on Wednesday. Apple — The iPhone maker's stock rose more than 3% after hitting its lowest level since June 2021 earlier in the week.

☆ A top digital health investor predicts that a big tech company like Amazon or Salesforce will buy a mountain of patient health records in 2023
▼ + stars: | 2022-12-28 | by ( Blake Dodge | ) www.businessinsider.com time to read: +4 min

She said that next year, a tech giant will buy an electronic medical records company. Missy Krasner, who oversaw several health efforts at Google and Amazon, predicts that a large technology firm will buy a mountain of patient medical records in 2023. EHR companies provide software that doctors use to store and analyze medical records and other kinds of patient data. The timing is right for big tech to make a play for patient dataThe timing may be right for a big tech company to buy its way into owning patient data. Tech companies have made seismic investments in this area.

"It's a combination of the FTC and (Justice Department) being willing to litigate and the fact that companies are fighting back," Grosberg said. More recently, they have lost four attempts to block mergers in court, though they are appealing two of the cases. The Justice Department did not immediately respond to requests for comment. Break-up fees that acquirers agree to pay their targets if their deal gets shot down by antitrust regulators are also on the rise. Many companies facing merger challenges say they will fight on, emboldened by the four court losses of the Justice Department and FTC.

In this light, artificial intelligence (AI) and emerging technology have become increasingly prevalent, propelling efforts to improve patient care, solutions, and overall healthcare outcomes. These groups have clinical, operational, and technology experts working together to identify actual healthcare delivery and operational problems that can be addressed using AI, emerging technologies, and digital health tools. The hospital established specialized and certified applied healthcare AI programs tailored to healthcare staff for promoting AI and emerging technology capabilities and their applications in healthcare. As a result, multiple value-driven AI and emerging technology systems built in-house have been deployed in various clinical and operational units. Constant progress: Healthcare providers need to set clear boundaries for adopting AI and emerging technology as tools for supporting evidence-based medicine.

☆ Siemens Healthineers, GE Healthcare eye Medtronic units - Bloomberg News
▼ + stars: | 2022-12-15 | by ( ) www.reuters.com time to read: +1 min

Dec 15 (Reuters) - Siemens Healthineers AG (SHLG.DE) and General Electric Co's (GE.N) healthcare business are weighing a potential acquisition of two units being spun off by Medtronic Plc (MDT.N), Bloomberg reported on Thursday, citing people familiar with the matter. Medtronic, the world's largest standalone medical device maker, had announced plans in October to spin off the two units - patient monitoring and respiratory interventions - as it seeks to streamline its portfolio. Bloomberg reported on Thursday that Medtronic was also open to a sale at the right price and the businesses could be valued at more than $7 billion. Medtronic and GE Healthcare did not immediately respond to Reuters request for comment, while Siemens Healthineers declined to comment. Medtronic has been restructuring its business over the last few years in a bid to increase the pace of its revenue growth.

☆ Limiting volatility has driven Clarkston Founders fund to outperform in 2022
▼ + stars: | 2022-12-12 | by ( Alex Harring | ) www.cnbc.com time to read: +4 min

The Clarkston Founders Institutional Fund has always tried to avoid volatility. The Founder's Fund has lost about 2.8% in 2022, notably outperforming other mid-cap value funds, which are down an average 7.2%, and a Morningstar benchmark index, which is lower by 5.6%, all through Dec. 9. As a result, the $610-million fund has a below average beta — a measurement of volatility relative to the broad market — of 0.85, according to Morningstar, versus 1.08 for all mid-cap value funds. The fund ranks in the 15th percentile of all mid-cap value funds in 2022, and is in the 23rd percentile over the past five years. Clarkston's investment policy emphasizes what it calls "quality value" stocks, regarded as high quality and considered undervalued relative to their long-term cash flows.

"The legal precedent is not on the side of the FTC," said Andre Barlow, an antitrust lawyer at Doyle, Barlow & Mazard PLLC. Barlow pointed to three recent mergers challenged by the FTC or Justice Department that were ultimately allowed to proceed. Those cases share something else in common with the proposed Microsoft deal: in each instance, a company would merge with a supplier in a so-called "vertical" merger. "Vertical merger challenges are really difficult to win so it will be an uphill battle for the FTC," said Roger Alford, who teaches law at the University of Notre Dame. Reuters reported last month that Microsoft was expected to offer remedies to EU antitrust regulators in the coming weeks to stave off formal objections to the deal.

Dec 8 (Reuters) - General Electric Co's (GE.N) healthcare division is aiming to have a medium-term organic revenue growth in the mid-single-digits, the unit's Chief Executive Officer Peter Arduini said at an investor day conference on Thursday. China, which accounts for about 15% of total GE Healthcare sales, would also help drive growth as there is a pent-up demand in the market, Arduini said. GE Healthcare also expects medium-term adjusted core earnings margin to be close to 20%. Zodl highlighted challenges such as macroeconomic factors, supply chain challenges, restructuring action undertaken in 2022 along with planned investment in research and development which may weigh on its core earnings margin. The healthcare company had revenue of around $18 billion last year, with about half of it from recurring sources, GE Healthcare said in a presentation.

☆ GE Healthcare Plans to Reduce Debt and Costs, Pursue Tuck-In Acquisitions
▼ + stars: | 2022-12-08 | by ( Nina Trentmann | ) www.wsj.com time to read: +5 min

As a stand-alone company, GE Healthcare will also look to improve its working capital and lower logistics costs, Mr. Zodl said. GE Healthcare will also take a look at its real estate holdings and target over 100 sites, executives said. Ratings firms S&P Global Ratings, Fitch Ratings and Moody’s Investors Service have all given GE Healthcare an investment-grade rating. PREVIEWApart from reducing debt and costs, GE Healthcare will scout for potential tuck-in acquisition targets, Chief Executive Peter Arduini said. GE retains a 19.9% stake in GE Healthcare.

☆ Oppenheimer upgrades General Electric, says the industrial giant's outlook is improving
▼ + stars: | 2022-12-06 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

Investors should load up on General Electric heading into 2023, according to Oppenheimer. Analyst Christopher Glynn upgraded the industrial giant to outperform from perform, saying several factors are boosting confidence in the stock next year, including a planned spinoff of its health care division and strong momentum for its aviation business. "Our Outperform rating reflects strong Aviation momentum along industry recovery path, with strong execution amidst widespread industry supply-chain challenges impacting the commercial business and internal production challenges serving military markets," Glynn wrote in a Monday note. General Electric is planning to split into three separate public companies by early 2024, separated into GE Aerospace, GE HealthCare and GE Vernova . General Electric has performed better than the S & P 500 this year, down just 10% compared to the 17% fall in the broader market index.

☆ GE Puts $31 Billion Value on Spinoff of GE HealthCare Technologies
▼ + stars: | 2022-12-01 | by ( Thomas Gryta | ) www.wsj.com time to read: 1 min

The planned spinoff of GE HealthCare Technologies is part of General Electric’s overall plan to split into three separate public companies. General Electric Co. set the terms for the spinoff of its healthcare division, putting an initial value of roughly $31 billion on the soon-to-be-public company. GE said current shareholders would get one share in the new GE HealthCare Technologies Inc. for every three shares they hold in GE. The separation is set for Jan. 3 after the markets close, and the new shares will trade on Nasdaq under the symbol GEHC.

☆ This startup helps Fortune 500 companies build computer vision AI models. Check out the 44-slide animated pitch deck V7 used to raise a $33 million Series A.
▼ + stars: | 2022-11-29 | by ( Riddhi Kanetkar | ) www.businessinsider.com time to read: +3 min

The startup allows machine learning teams to build computer vision AI models. Computer vision models extract information from visual data sources, such as images and videos, to help computers and machines to better interpret these visual inputs. Many computer vision models are powered by machine learning technology, but this process can be time-consuming to engineer. This helps companies to develop AI models much faster and cuts down on the time needed to manage machine learning data, according to V7. V7 labels data automatically, so that teams do not have to annotate the data from scratch.

☆ What Cramer is watching Tuesday — UPS and Halliburton beat, Meta catches price cuts
▼ + stars: | 2022-10-25 | by ( Jim Cramer | ) www.cnbc.com time to read: +3 min

What I am looking at Oct. 25, 2022 Delivery service UPS beats — Q3 adjusted EPS of $2.99 versus consensus $2.85 — but only reaffirms guidance. Club holding Meta Platforms (META) gets two more price cuts: KeyBanc lowers to $175 from $196, Jefferies cuts to $200 from $225. (Jim Cramer's Charitable Trust is long HAL, META, STZ. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. A United Parcel Service (UPS) truck delivers boxes in Manhattan on April 26, 2022 in New York City.

☆ The world is running out of helium. Here's why doctors are worried.
▼ + stars: | 2022-10-22 | by ( Caroline Hopkins | Nbc News Contributor Caroline Hopkins Is A Health | Science Journalist Who Covers Cancer Treatment For Precision Oncology News. She Is A Graduate Of The Columbia University Graduate School Of Journalism. | ) www.nbcnews.com time to read: +7 min

A global helium shortage has doctors worried about one of the natural gas’s most essential, and perhaps unexpected, uses: MRIs. Now, four of five major U.S. helium suppliers are rationing the element, said Phil Kornbluth, president of Kornbluth Helium Consulting. That’s where helium comes in: With a boiling point of minus 452 degrees Fahrenheit, liquid helium is the coldest element on Earth. “Without helium, MRIs would have to shut down.”Manufacturers like GE Healthcare and Siemens Healthineers recognize this vulnerability. As doctors dread possible worst-case scenarios, scientists who use liquid helium for research are already there.

☆ David Einhorn says he's bearish because the Fed's 'official policy is to make the stock market go down'
▼ + stars: | 2022-10-20 | by ( Yun Li | ) www.cnbc.com time to read: +2 min

Greenlight Capital's David Einhorn, who is crushing the market with double-digit returns this year, is selling stocks as the Federal Reserve continues to deflate the market with aggressive rate hikes. However, higher interest rates also discourage investments and in turn crunch supply, which is most evident in the housing market. "The most glaring area might be in housing, where higher rates lead to reduced supply despite widespread shortage," Einhorn said. That compares with a 23.9% decline for the S & P 500 during the same period as the benchmark tumbled into a bear market. Further, high short-term interest rates provide competition for gold," Einhorn said.

☆ Moelis hires former Morgan Stanley bankers for healthcare dealmaking
▼ + stars: | 2022-10-18 | by ( David Carnevali | ) www.reuters.com time to read: +1 min

NEW YORK, Oct 18 (Reuters) - Moelis & Co. has hired two former Morgan Stanley bankers, Arek Kurkciyan and Dennis Crandall, as managing directors to help drive dealmaking in the life sciences and outsourced pharmaceutical services sectors for the investment bank. Both Kurkciyan and Crandall were managing directors in the healthcare investment banking unit at Morgan Stanley. Register now for FREE unlimited access to Reuters.com RegisterIn their previous roles at Morgan Stanley, both bankers worked on significant deals involving large healthcare corporations and financial sponsors. In recent months, Moelis has been attempting to shore up its healthcare M&A unit. It recently hired another senior banker Igor Sokolovsky to help with dealmaking across sectors, with a special focus on healthcare.

☆ How to invest with the S&P 500 at risk of falling up to 28% in the next 3 months as valuations contract, according to an investment chief and 5-star fund manager
▼ + stars: | 2022-10-14 | by ( James Faris | ) www.businessinsider.com time to read: +5 min

Valuations in past downturns suggest that the S&P 500 could fall another 28%. Don't be surprised if the S&P 500 plummets by up to 28% in the next three months, said Doug Ramsey, chief investment officer of The Leuthold Group, in a recent interview with Insider. "The stock market is not just a discounter of future economic activity — it's also a driver by the wealth effect and the confidence effect," Ramsey said. Ramsey added: "They acknowledged the power of the wealth effect, and they've certainly harnessed the power of the wealth effect on the way up. That means being willing to quickly pivot off an incorrect view — including if his theory that the S&P 500 will fall below 3,000 proves to be wrong.

☆ Justice Department's fight with JetBlue and American Airlines heads to court
▼ + stars: | 2022-09-27 | by ( Leslie Josephs | ) www.cnbc.com time to read: +4 min

An American Airlines plane lands on a runway near a parked JetBlue plane at the Fort Lauderdale-Hollywood International Airport on July 16, 2020 in Fort Lauderdale, Florida. The Justice Department heads to court in Boston on Tuesday in hopes of undoing a year-and-a-half-old pact between American Airlines and JetBlue Airways in the Northeast U.S. Last September, the Justice Department along with the attorneys general of six states and the District of Columbia sued to block the partnership, which was approved in the final days of the Trump administration. The antitrust trial will be a test for President Joe Biden's Justice Department, which has been tasked with taking a hard stance against threats to competition. Earlier this month, a federal judge denied the Justice Department's bid to block UnitedHealth's acquisition of Change Healthcare.

Search resuls for: "GE Healthcare"

25 mentions found